Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
R&D InsightY2018

Developing non-traditional antimicrobial therapies & preventatives: Events on 22 April (ECCMID, Madrid) and 14 June (Washington)

Dear All: As recently summarized by Pew Trusts’ reviews of the antimicrobial pipeline, there is a lot of interest in non-traditional (alternative) …

Read More >
IncentivesY2018

Novo’s REPAIR Fund: Application Template Out (15 May Deadline) + Sr. Associate Job Opening

Dear All: The new Novo REPAIR impact fund ($165m over 5 years for antibacterials) is now open for applications — …

Read More >
IncentivesY2018

Calls for proposals: US CDC, UK-China, Wellcome Trust

Dear All: As we head into the Easter and Passover weekend, three new calls for proposals have emerged! Perhaps one …

Read More >
JobsY2018

Leadership opportunities in AMR: PACCCARB, BARDA’s new DRIVe initiative

Dear All: If you are interested in public service, two very exciting groups of opportunities have recently emerged. First, PACCARB (the US …

Read More >
R&D InsightY2018

EU Joint Action on AMR & Health-Care Associated Infections (EU-JAMRAI): Passing the DRIVE-AB torch?

Dear All: Recently announced is a new EU Joint Action on Antimicrobial Resistance (AMR) & Health-Care Associated Infections (HCAI). Its …

Read More >
JobsY2018

Wellcome Trust: RFP to develop a business plan for a sustainable clinical trial network

Dear All: Just released today is an RFP (see text just below my signature) to develop a business plan for the …

Read More >
IncentivesY2018

Novo’s $165m REPAIR fund seeks to support projects from LO to Phase 1

Dear All: Just announced today (press release, website), Novo Holdings has created a $165m impact fund that seeks to support novel …

Read More >
R&D InsightY2018

(Another!) FDA trial design workshop: Complex innovative designs

Dear All: Adding to the 19 Mar 2018 (Designs for Rare Diseases) and 16 Apr 2018 (Inclusion/Exclusion criteria) workshops already …

Read More >
R&D InsightY2018

TATFAR’s 2018 meeting: Live streaming of 7 Mar opening session

Dear All: On 7-9 Mar 2018, the Transatlantic Task Force on Antimicrobial Resistance (TATFAR) will meet in Atlanta, GA to …

Read More >
IncentivesY2018

CARB-X Application Round #3 goes live!

Dear All: The wait is over — CARB-X has today released a call for new applications! The call has an interesting 2-round …

Read More >
R&D InsightY2018

Duke-Margolis & FDA: Workshop on stats & methods for rare diseases

Dear All: Duke-Margolis and FDA have now announced a 19 Mar 2018 workshop entitled Utilizing Innovative Statistical Methods and Trial Designs in Rare …

Read More >
JobsY2018

More jobs! CARB-X also has openings

Dear All: Building on my recent note about a search for the G20 secretariat lead, we now have CARB-X getting into job creation …

Read More >
R&D InsightY2018

Two things: WHO’s looking GLASS + FDA’s advances with PDUFA VI

Dear All: Two things today. Unrelated, but both relevant! WHO’s GLASS: WHO’s Global Antimicrobial Resistance Surveillance System (GLASS) was created during October …

Read More >
JobsY2018

Secretariat Lead of the G20’s Global AMR R&D Hub: Could this be you?

Dear All: As you may know, the G20 are establishing an AMR R&D Hub that will encourage and promote coordinated …

Read More >
R&D InsightY2018

Potpourri: QIDP Q&A, BEAM Alliance paper and meeting, Duke-Margolis workshop on inclusion/exclusion criteria

Dear All: And then there are days when the floodgates open and things just appear! The amount of stuff afoot …

Read More >
Media & GraphicsY2018

CARB-X is seeking additional accelerators to expand support for its pipeline

Dear All: It is exciting to see that CARB-X today announced that it is seeking to partner with up to 6 additional …

Read More >
IncentivesWonkish

Push! Pull! Push! Pull! / Highlights from Davos 2018

Dear All: Three important documents were released at / during / around the World Economic Forum meeting that occurred this …

Read More >
Media & GraphicsY2018

Updated Pew Pipeline analysis of both traditional and non-traditional antimicrobial agents in development

Dear All: To start the new year, I’ve learned that Pew has updated their pipeline analysis. First released in Feb …

Read More >
Media & GraphicsY2017

WHO Priority Pathogens List paper is published; Industry action report to be released

Dear All: First, the methods behind the WHO Priority Pathogens List (PPL, released on 25 Feb 2017) have now been published by Tacconelli et …

Read More >
R&D InsightY2017

Debut of FDA Susceptibility Test Interpretive Criteria (STIC) website

Dear All: I knew that the idea of an online and frequently updated website for FDA-recognized Susceptibility Test Interpretive Criteria …

Read More >
Scroll to Top